AirSculpt Technologies, Inc. (AIRS)
USD 5.85
(-7.0%)
USD 5.85
(-7.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 99.66 Million USD | -7.41% |
| 2022 | 107.64 Million USD | 7.02% |
| 2021 | 100.58 Million USD | 102.11% |
| 2020 | 49.76 Million USD | 10.35% |
| 2019 | 45.1 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 100.45 Million USD | 1.61% |
| 2024 Q1 | 98.86 Million USD | -0.8% |
| 2023 Q4 | 99.66 Million USD | -1.22% |
| 2023 FY | 99.66 Million USD | -7.41% |
| 2023 Q2 | 112.42 Million USD | -0.93% |
| 2023 Q1 | 113.47 Million USD | 5.42% |
| 2023 Q3 | 100.89 Million USD | -10.26% |
| 2022 Q2 | 104.78 Million USD | 2.98% |
| 2022 Q1 | 101.75 Million USD | 1.16% |
| 2022 FY | 107.64 Million USD | 7.02% |
| 2022 Q4 | 107.64 Million USD | 0.41% |
| 2022 Q3 | 107.21 Million USD | 2.31% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 100.58 Million USD | 102.11% |
| 2021 Q2 | 98.58 Million USD | 0.0% |
| 2021 Q4 | 100.58 Million USD | -0.79% |
| 2021 Q3 | 101.38 Million USD | 2.84% |
| 2020 FY | 49.76 Million USD | 10.35% |
| 2020 Q4 | 49.76 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 45.1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 93.403% |
| Addus HomeCare Corporation | 175.18 Million USD | 43.106% |
| Amedisys, Inc. | 487.21 Million USD | 79.543% |
| American Oncology Network, Inc. | 128.32 Million USD | 22.332% |
| Astrana Health, Inc. | 321.01 Million USD | 68.952% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 93.352% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | 13.235% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -814.718% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -1792.311% |
| COMPASS Pathways plc | 33.04 Million USD | -201.567% |
| DocGo Inc. | 46.49 Million USD | -114.353% |
| The Ensign Group, Inc. | 1.87 Billion USD | 94.674% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -128.413% |
| InnovAge Holding Corp. | 113.03 Million USD | 11.826% |
| Assure Holdings Corp. | 14.8 Million USD | -573.205% |
| The Joint Corp. | 16.73 Million USD | -495.572% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 80.497% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -15067.097% |
| ModivCare Inc. | 1.14 Billion USD | 91.258% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -29870.561% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -2128.887% |
| Option Care Health, Inc. | 1.16 Billion USD | 91.455% |
| P3 Health Partners Inc. | 124.64 Million USD | 20.036% |
| P3 Health Partners Inc. | 124.64 Million USD | 20.036% |
| The Pennant Group, Inc. | 329.63 Million USD | 69.764% |
| Surgery Partners, Inc. | 3.06 Billion USD | 96.745% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -40072.025% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | 16.815% |
| The Oncology Institute, Inc. | 119.81 Million USD | 16.815% |